LUMEVOQ
LIVE

Serial Number

79252947

Owner

GENSIGHT BIOLOGICS

Attorney

John T.D. Bathke

Filing Date

Dec 21, 2018

Add to watchlist:

No watchlists yet
View on USPTO

LUMEVOQ Trademark

Serial Number: 79252947 • Registration: 5974489

LUMEVOQ is a trademark filed by GENSIGHT BIOLOGICS on December 21, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

GENSIGHT BIOLOGICS (3 trademarks)

74 RUE DU FAUBOURG SAINT-ANTOINE

Entity Type: 99

Trademark Details

Filing Date

December 21, 2018

Registration Date

February 4, 2020

Published for Opposition

November 19, 2019

Goods & Services

Education services in the nature of classes and seminars in the medical field and in particular that of eye diseases

Pharmaceutical products for the treatment of ocular diseases; Medicines for human purposes for the treatment of ocular diseases

Pamphlets and information bulletins in the field of ocular diseases; presentation folders; printed booklets in the field of ocular diseases; partially printed forms; printed teaching activity guides in the field of ocular diseases; educational books in the field of ocular diseases; information booklets in the field of ocular diseases; training manuals and instruction manuals for teaching purposes in the field of ocular diseases; instruction manuals in the field of ocular diseases; printed educational and training materials in the field of ocular diseases; instruction and teaching material, excluding apparatus, in the field of ocular diseases; educational publications, namely, books, booklets and instruction manuals in the field of ocular diseases; printed questionnaires on ocular diseases; specialist journals in the field of ocular diseases; printed teaching and instructional materials in the field of ocular diseases, all these products intended for patients and physicians in the medical field and in particular the field of eye diseases

Administrative business support staff services for patients with a view to submitting requests in the medical field in particular for the management of eye diseases

Scientific research in the field of eye diseases

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 4, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 5, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 18, 2020 FICS
FINAL DISPOSITION PROCESSED
May 18, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 4, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 4, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 19, 2019 NPUB
PUBLISHED FOR OPPOSITION
Nov 19, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Nov 15, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 30, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 30, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 30, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 15, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 18, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 18, 2019 CRFA
ASSIGNED TO LIE
Sep 17, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 11, 2019 TROA
REFUSAL PROCESSED BY IB
Apr 12, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 23, 2019 RFCS
REFUSAL PROCESSED BY MPU
Mar 23, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 17, 2019 RFCR
NON-FINAL ACTION WRITTEN
Mar 16, 2019 CNRT
ASSIGNED TO EXAMINER
Mar 16, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 8, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 4, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 28, 2019 REPR